ALZHEIMER DISEASE, EARLY ONSET
Clinical trials for ALZHEIMER DISEASE, EARLY ONSET explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER DISEASE, EARLY ONSET trials appear
Sign up with your email to follow new studies for ALZHEIMER DISEASE, EARLY ONSET, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could 'Zombie Cell' cleaners slow Alzheimer's? new trial underway
Disease control OngoingThis study tests whether senolytic drugs—medicines that clear out aging 'zombie' cells—are safe and workable for people with early Alzheimer's or mild memory problems. About 48 adults aged 60 and older with elevated tau protein will receive either the drug or a placebo. The main …
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 04:43 UTC
-
New Alzheimer's drug shows promise in Early-Stage trial
Disease control OngoingThis study tests a new drug called PMN310 in people with early Alzheimer's disease. The goal is to see if it is safe and if it can reduce harmful proteins in the brain. About 144 participants will receive multiple doses of the drug or a placebo. This is an early-phase trial, so t…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE1 • Sponsor: ProMis Neurosciences, Inc • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
Could a daily light-and-sound session help slow Alzheimer's?
Disease control OngoingThis study tests whether a device that delivers light and sound stimulation for 60 minutes each day can slow the decline in memory and daily living skills in people with mild to moderate Alzheimer's disease. About 670 participants will use either the active device or a sham (inac…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Cognito Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Brain pacemaker trial aims to slow Alzheimer's memory loss
Disease control ENROLLING_BY_INVITATIONThis study tests whether deep brain stimulation (DBS) can improve thinking and memory in people with early Alzheimer's disease. Two participants will have electrodes placed in a brain area that produces a key memory chemical. The goal is to see if daily, one-hour stimulation sess…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Can magnetic pulses boost memory in early Alzheimer's?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether a non-invasive brain stimulation technique called theta-burst stimulation (TBS) can help improve cognitive function in people diagnosed with young-onset Alzheimer's disease (before age 65). Researchers will enroll 70 participants aged 50-75 with mild t…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated May 26, 2026 04:41 UTC
-
Brain zapping shows promise for Alzheimer's memory loss
Symptom relief OngoingThis study tests whether a safe, painless brain stimulation technique called tDCS can boost memory and word learning in people with Alzheimer's disease. About 90 participants with either typical memory-loss Alzheimer's or a language-focused form will receive either real or fake s…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC
-
Could a High-Fat diet help slow Alzheimer's?
Symptom relief OngoingThis study looks at whether a ketogenic diet—a high-fat, low-carb diet that makes the body produce ketones—is practical and helpful for people with early Alzheimer's disease. The diet may provide an alternative fuel for brain cells and reduce inflammation. Researchers will follow…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated May 20, 2026 11:54 UTC
-
Scientists scan brains to track Alzheimer's proteins over time
Knowledge-focused OngoingThis study uses brain scans to measure two proteins, amyloid and tau, in people with different forms of Alzheimer's disease. Researchers want to see how these protein levels change over one year. The goal is to better understand the disease, not to test a treatment. About 60 adul…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 04:32 UTC